Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment. Pharm Pract (Granada) [Internet]. 2015 May 29 [cited 2026 Jan. 16];13(2):559. Available from: https://pharmacypractice.org/index.php/pp/article/view/559